$GALE Recent Headlines Top longs and shorts to watch

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$GALE Recent Headlines

Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck

Prognosticating 2014: Athersys Shares Will Continue To Climb 2:51 p.m. Jan. 7, 2014 - Seeking Alpha
Galena Biopharma rises as first patient enrolled in FBP study 8:10 a.m. Jan. 7, 2014 - Seeking Alpha
Galena Enrolls First Patient in GALE-301 Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 6:10 a.m. Jan. 7, 2014 - benzinga.com
Biotech Stocks Under $10 With Huge Upside Potential for 2014 7:39 a.m. Jan. 3, 2014 - 247WallSt.com
Galena Biopharma rallies, SA bull upbeat for 2014 3:02 p.m. Dec. 31, 2013 - Seeking Alpha
The Young And Restless Portfolio Update: Heading Into 2014 After A Fabulous 2013 10:07 a.m. Dec. 31, 2013 - Seeking Alpha
Galena Biopharma Inc. (GALE) Shares March Higher, Can It Continue? - Tale of the Tape 8:41 a.m. Dec. 31, 2013 - Zacks.com
Team Alpha Portfolio Updates: 2014 Could Be The Year Of The Dividend Champs 9:00 a.m. Dec. 30, 2013 - Seeking Alpha
Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains 6:12 a.m. Dec. 27, 2013 - 247WallSt.com
Team Alpha Portfolios For Retirement: When Is Enough, Enough? 6:41 a.m. Dec. 25, 2013 - Seeking Alpha
Investing In A Rising Interest Rate Environment 11:55 a.m. Dec. 23, 2013 - Seeking Alpha
Will Galena's Post-Holiday Charm Continue? 11:51 a.m. Dec. 19, 2013 - Seeking Alpha
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 10:12 a.m. Dec. 12, 2013 - TheStreet.com
3 Breast Cancer Drugs That Could Boost Your Portfolio 4:45 p.m. Dec. 11, 2013 - Seeking Alpha
Today's Dead Cat Bounce Stock: Galena Biopharma (GALE) 3:01 p.m. Dec. 11, 2013 - TheStreet.com
Can The Uptrend Continue for Galena Biopharma Inc. (GALE)? - Tale of the Tape 7:15 a.m. Dec. 10, 2013 - Zacks.com
4 Reasons Why Galena Biopharma Is Headed Higher 1:05 p.m. Dec. 4, 2013 - Wall St. Cheat Sheet
Perilous Reversal Stock: Galena Biopharma (GALE) 11:40 a.m. Dec. 3, 2013 - TheStreet.com
Galena rallies, article calls pipeline "rich" 11:31 a.m. Dec. 2, 2013 - Seeking Alpha
Biotech Stocks Partying Like It's 1999 7:00 a.m. Dec. 2, 2013 - TheStreet.com


Morning Buzzers: Facebook Inc, Galena Biopharma Inc, Plug Power Inc, Cell Therapeutics Inc, Advanced Micro Devices 10:50 a.m. Jan. 7, 2014 - ACCESSWIRE
Galena Biopharma Enrolls First Patient in GALE-301 (Folate Binding Protein (FBP)) Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer 7:05 a.m. Jan. 7, 2014 - GlobeNewswire
Special Stocks Analysis: ImmunoCellular Therapeutics, Vodafone Group, BlackBerry Ltd, Galena Biopharma Inc 10:04 a.m. Dec. 24, 2013 - ACCESSWIRE
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on FB, TC, OCZ, and GALE 12:21 a.m. Dec. 5, 2013 - ACCESSWIRE
Breakfast News: Hewlett-Packard Company, Alpha Natural Resources, Yahoo! Inc, Galena Biopharma 8:51 a.m. Dec. 4, 2013 - ACCESSWIRE
Corporate News, Acquisitions: Herbalife Ltd, 3D Systems Corporation, Federal National Mortgage Association, Galena Biopharma Inc, Oncomed Pharmaceuticals 8:44 a.m. Dec. 4, 2013 - PR Newswire
Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference 7:05 a.m. Dec. 4, 2013 - GlobeNewswire
Healthcare Sector Announce Awards, Conference Participation, Partnerships, and Closure of Public Offering - Research Report on Regeneron, Alnylam, Galena Biopharma, Amedisys, and Aeterna Zentaris 8:00 a.m. Dec. 3, 2013 - PR Newswire
TrendingWallStreet.com Begins Volume Coverage on MYGN, FNMA, ABX, and GALE 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
Galena Biopharma to Present at the 25th Annual Piper Jaffray Healthcare Conference 7:05 a.m. Nov. 26, 2013 - GlobeNewswire
HIMX, GALE, INTC and NVGN added to NASDAQ Active Stock Watch List at GSR 10:16 a.m. Nov. 25, 2013 - ACCESSWIRE
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
Quarterly Reports and Events - Research Report on Mettler-Toledo, Galena Biopharma, Achillion, Wright Medical, and OXiGENE 8:00 a.m. Nov. 15, 2013 - PR Newswire
ZLCS, CLRX, DSCO and GALE added to NASDAQ Active Stock Watch List at GSR 10:19 a.m. Nov. 11, 2013 - ACCESSWIRE
Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference 7:05 a.m. Nov. 11, 2013 - GlobeNewswire
Galena Biopharma Reports Third Quarter 2013 Results 4:35 p.m. Nov. 6, 2013 - GlobeNewswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 69

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 104

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 107

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 81

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 79

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading

Top 5 Most Recently Viewed Articles

Larry Chen's Transformative Journey in Automotive Photography

Updated Category News Views 460

Celebrating 20 Years of Automotive Photography Renowned automotive photographer Larry Chen presents his first-ever book titled Life at Shutter Speed: Two Decades of Larry Chen Photography. This extensive 400-page work features exceptional highlights from Chen's impressive career, along with captivating never-before-seen images. What’s Inside the Book? Life at Shutter...

Continue Reading
Kemper Corporation Achieves Record Stock High of $71.71

Updated Category News Views 157

Kemper Corporation Achieves New Stock Milestone Kemper Corporation (NYSE: KMPR) has reached an impressive milestone by achieving a remarkable 52-week high of $71.71. This achievement not only signifies a substantial uptrend for the diversified insurance holding but also reflects a commendable 67.95% increase in its stock value over the past year. The rising confidence...

Continue Reading
Rising Online Vaping Markets: A Challenge for Local Stores

Updated Category News Views 114

Challenges Faced by Local Convenience Stores in Quebec Local convenience stores in Quebec are confronting significant challenges due to the rise of online vaping sales. As these businesses grapple with a ban on flavored vapor products, introduced by Health Minister Christian Dubé, they are witnessing a shift in consumer behavior. This change has driven many customers to...

Continue Reading
Krispy Kreme Shareholders Invited to Join Class Action Lawsuit

Updated Category News Views 485

Krispy Kreme Investors: The Class Action Lawsuit Explained Krispy Kreme, Inc. (NASDAQ: DNUT) is facing a class action lawsuit that is generating significant attention among investors. This suit has been initiated by Robbins LLP following concerns about misleading statements made by the company's executives regarding its partnership with McDonald's. For anyone invested in...

Continue Reading
DexCom, Inc. Class Action Notice: Your Chance to Join Efforts

Updated Category News Views 62

Important Warning for DexCom, Inc. Shareholders Investors holding shares of DexCom, Inc. (NASDAQ: DXCM) should be aware of a critical opportunity to engage in a class action lawsuit. This notice emphasizes the essential details for shareholders who purchased shares during the specified class period. Your Participation Matters Shareholders are urged to reach out promptly...

Continue Reading